Lonza Group AG Share Price Swiss Exchange
Equities
CH0013841017
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
||
495.3 CHF | 0.00% |
14/05 | Swiss Market Index Edges Up Ahead of Inflation Report | MT |
14/05 | Global markets live: Apple, Sony, Vodafone, Booking, Walmart... |
Sales 2024 * | 6.66B 7.41B 619B | Sales 2025 * | 7.63B 8.48B 709B | Capitalization | 36.13B 40.2B 3,360B |
---|---|---|---|---|---|
Net income 2024 * | 893M 994M 83.04B | Net income 2025 * | 1.11B 1.23B 103B | EV / Sales 2024 * | 5.84 x |
Net Debt 2024 * | 2.72B 3.02B 253B | Net Debt 2025 * | 3.32B 3.69B 309B | EV / Sales 2025 * | 5.17 x |
P/E ratio 2024 * |
40.5
x | P/E ratio 2025 * |
32.4
x | Employees | - |
Yield 2024 * |
0.9% | Yield 2025 * |
1.06% | Free-Float | 96.79% |
Latest transcript on Lonza Group AG
Managers | Title | Age | Since |
---|---|---|---|
Albert Baehny
CEO | Chief Executive Officer | 72 | 25/17/25 |
Philippe Deecke
DFI | Director of Finance/CFO | 52 | 01/21/01 |
Maria Nunez
COO | Chief Operating Officer | 55 | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Barbara Richmond
BRD | Director/Board Member | 63 | 16/14/16 |
Director/Board Member | 66 | 16/14/16 | |
Marion Helmes
BRD | Director/Board Member | 58 | 05/22/05 |
1st Jan change | Capi. | |
---|---|---|
+49.66% | 56.95B | |
-7.43% | 39.32B | |
-4.42% | 28.37B | |
+12.17% | 26.45B | |
-18.18% | 19.41B | |
+28.92% | 12.54B | |
+25.82% | 12.21B | |
-1.26% | 12.15B | |
-11.11% | 11.05B |